Menora Mivtachim Reaches Class Action Settlement Over Heart Attack Claims

The Central District Court in Lod has approved a settlement agreement in a class action lawsuit against Menora Mivtachim Insurance, addressing the rejection of claims submitted by policyholders seeking compensation for acute myocardial infarction.

The lawsuit focused on health insurance policies providing critical illness coverage, which grant a lump-sum financial payment upon the diagnosis of a listed severe illness, including acute heart attacks. According to the plaintiff, the insurer relied on medical definitions and threshold values established in circulars issued by the Commissioner of Capital Markets, Insurance and Savings from 2013 and 2015.

Compensation and Policy Adjustments

Under the terms of the settlement, eligible policyholders will be entitled to 90% of the nominal insurance amount, alongside potential premium refunds in appropriate cases. Furthermore, Menora committed to refraining from rejecting heart attack claims based solely on a troponin level lower than 1 ng/ml, mandating instead that claims be evaluated in accordance with prevailing hospital standards at the relevant time.

"The settlement ensures that policyholders whose legitimate claims were previously dismissed due to outdated medical thresholds will finally receive the compensation they are owed." — Legal Counsel

Eligibility Criteria

The defined class includes individuals insured by Menora who held critical illness coverage encompassing acute myocardial infarction, submitted a claim for insurance benefits, and faced rejection partially or entirely due to the troponin criteria.

• Primary Claim Period: From July 22, 2021, until the filing of the settlement approval request on March 9, 2026.

• Extended Period: Cases occurring between January 1, 2021, and July 21, 2021, provided the policy was issued or renewed after November 25, 2020.

To implement the agreement, Menora will review previously rejected files based on medical grounds, including those citing troponin levels or general policy non-compliance, ensuring fair financial redress for affected clients.